Short Interest in Lifeward Ltd. (NASDAQ:LFWD) Increases By 18.8%

Lifeward Ltd. (NASDAQ:LFWD) was the target of a large increase in short interest in February. As of February 13th, there was short interest totaling 2,351,929 shares, an increase of 18.8% from the January 29th total of 1,979,952 shares. Based on an average trading volume of 241,976 shares, the short-interest ratio is currently 9.7 days. Approximately 13.1% of the company’s stock are sold short. Approximately 13.1% of the company’s stock are sold short. Based on an average trading volume of 241,976 shares, the short-interest ratio is currently 9.7 days.

Institutional Investors Weigh In On Lifeward

A number of institutional investors and hedge funds have recently modified their holdings of LFWD. Virtu Financial LLC increased its holdings in shares of Lifeward by 158.0% in the fourth quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after acquiring an additional 37,037 shares in the last quarter. Jane Street Group LLC increased its stake in Lifeward by 77.3% during the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after purchasing an additional 29,927 shares in the last quarter. HRT Financial LP raised its holdings in shares of Lifeward by 149.7% during the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after acquiring an additional 29,423 shares during the period. Finally, Citadel Advisors LLC lifted its position in Lifeward by 1,271.8% in the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after acquiring an additional 198,406 shares in the last quarter. 26.76% of the stock is owned by institutional investors.

Lifeward Stock Performance

Shares of Lifeward stock traded down $0.41 during trading on Wednesday, reaching $5.99. The company’s stock had a trading volume of 20,485 shares, compared to its average volume of 28,396. Lifeward has a one year low of $4.14 and a one year high of $35.40. The stock has a 50-day moving average price of $7.08 and a two-hundred day moving average price of $7.47.

Analyst Ratings Changes

LFWD has been the topic of a number of recent research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Lifeward in a research note on Thursday, January 22nd. HC Wainwright lowered their price objective on Lifeward from $156.00 to $54.00 and set a “buy” rating on the stock in a report on Tuesday, November 18th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $51.00.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.